Table 4 |
|||||
|
AR exon 1 CAG Repeat length and family history in the NHS and the WHS |
|||||
|
Family history |
Genotypea [CAG]n |
1990–1996 OR (95% CI)b |
1998–2000 OR (95% CI)b |
WHS OR (95% CI)b |
NHS and WHS Combined OR (95% CI)b |
|
|
|||||
|
no |
<22 |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
|
no |
≥22 |
0.9 (0.8 to 1.2) |
1.0 (0.7 to 1.4) |
0.7 (0.5 to 1.0) |
1.0 (0.9 to 1.2) |
|
yes |
<22 |
1.0 (0.6 to 1.7) |
2.0 (0.9 to 4.2) |
1.6 (0.8 to 3.0) |
1.1 (0.9 to 1.5) |
|
yes |
≥22 |
1.7 (1.2 to 2.4) |
1.6 (0.9 to 2.6) |
1.1 (0.7 to 1.8) |
1.3 (1.1 to 1.6) |
|
|
|||||
|
no |
<22 |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
|
no |
≥23 |
0.9 (0.7 to1.2) |
0.9 (0.7 to 1.3) |
0.7 (0.5 to 1.0) |
1.0 (0.9 to 1.2) |
|
yes |
<22 |
1.0 (0.8 to 1.4) |
1.9 (0.9 to 4.1) |
1.6 (0.8 to 3.0) |
1.1 (0.9 to 1.5) |
|
yes |
≥23 |
1.8 (1.2 to 2.5) |
1.5 (0.9 to 2.6) |
1.0 (0.6 to 1.5) |
1.4 (1.1 to 1.8) |
|
|
|||||
|
no |
<22 |
1.00 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
|
no |
≥25 |
1.0 (0.8 to 1.4) |
0.9 (0.6 to 1.3) |
0.7 (0.5 to 1.1) |
1.0 (0.9 to 1.2) |
|
yes |
<22 |
1.1 (0.6 to 1.8) |
1.8 (0.9 to 4.0) |
1.6 (0.8 to 3.0) |
1.1 (0.9 to 1.5) |
|
yes |
≥25 |
2.0 (1.3 to 3.1) |
1.5 (0.7 to 3.0) |
0.7 (0.4 to 1.3) |
1.5 (1.1 to 2.0) |
|
|
|||||
|
no |
<22 |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
1.0 (Ref.) |
|
no |
≥27 |
1.1 (0.7 to 1.7) |
1.4 (0.8 to 2.5) |
0.8 (0.5 to 1.3) |
1.1 (0.9 to 1.4) |
|
yes |
<22 |
1.1 (0.6 to 1.9) |
2.0 (0.9 to 4.6) |
1.6 (0.8 to 3.0) |
1.1 (0.9 to 1.6) |
|
yes |
≥27 |
1.6 (0.8 to 3.1) |
2.1 (0.7 to 6.5) |
0.7 (0.3 to 1.8) |
1.4 (0.9 to 2.1) |
|
|
|||||
|
aAR genotype defined as having one or more long alleles ≥22, 23, 25, or 27 versus both alleles <22; bunconditional, unadjusted logistic regression. AR, androgen receptor; CI, confidence interval; NHS, Nurses' Health Study; OR, odds ratio; Ref., Reference category; WHS, Women's Health Study. |
|||||
|
Cox et al. Breast Cancer Research 2006 8:R54 doi:10.1186/bcr1602 |
|||||